1HAK
CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLACENTAL ANNEXIN V COMPLEXED WITH K-201 AS A CALCIUM CHANNEL ACTIVITY INHIBITOR
1HAK の概要
エントリーDOI | 10.2210/pdb1hak/pdb |
分子名称 | ANNEXIN V, 4-[3-{1-(4-BENZYL)PIPERODINYL}PROPIONYL]-7-METHOXY-2,3,4,5-TERTRAHYDRO-1,4-BENZOTHIAZEPINE (3 entities in total) |
機能のキーワード | annexin v, lipocortin v, endonexin ii, placenta anticoagulant protein-i, 35kda calelectrin, inhibitor of blood coagulation, calcium/phospholipid-binding, calcium-phospholipid-binding complex |
由来する生物種 | Homo sapiens (human) |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 72810.61 |
構造登録者 | |
主引用文献 | Kaneko, N.,Ago, H.,Matsuda, R.,Inagaki, E.,Miyano, M. Crystal structure of annexin V with its ligand K-201 as a calcium channel activity inhibitor. J.Mol.Biol., 274:16-20, 1997 Cited by PubMed Abstract: The crystal structure of recombinant human annexin V complexed with K-201, an inhibitor of the calcium ion channel activity of annexin V, was solved at 3.0 A by molecular replacement including the apo and high-calcium forms. K-201 was bound at the hinge region cavity formed by the N-terminal strand and domains II, III and IV, at the side opposite the calcium and membrane-binding surface, in an L-shaped conformation. Based on the complex and other annexin structures, K-201 is proposed to restrain the hinge movement of annexin V in an allosteric manner, resulting in the inhibition of calcium movement across the annexin V molecule. PubMed: 9398511DOI: 10.1006/jmbi.1997.1375 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (3 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード